Envarsus Pa 4 mg (Tacrolimus TABLET (EXTENDED-RELEASE)) 4 MG

ENVARSUS PA 4 MG is an extended-release tablet containing tacrolimus, used for immunosuppression. This medication helps prevent organ rejection after transplants. Learn more about its uses and effects.

Strength

4 MG

Manufacturer / TM Owner

ENDO OPERATIONS LTD.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

ENVARSUS PA 4 MG is primarily used to prevent organ rejection in transplant patients. Tacrolimus works by suppressing the immune system, which helps the body accept the transplanted organ. This medication is often prescribed for kidney, liver, or heart transplants. Patients should follow their healthcare provider's instructions for proper use.

Side Effects

Common effects of ENVARSUS PA 4 MG may include headaches, tremors, or gastrointestinal issues. Some users might experience changes in blood pressure or blood sugar levels. It's important to monitor for any unusual symptoms and consult a healthcare provider if concerns arise.

Precautions & Warnings

ENVARSUS PA 4 MG should be handled with care, especially regarding dosage and administration. It is crucial to follow the prescribed schedule and avoid crushing or chewing the extended-release tablets. Patients should be aware of potential interactions with other medications and discuss any existing health conditions with their healthcare provider.

Avoid Interactions

ENVARSUS PA 4 MG may interact with various medications, including certain antibiotics, antifungals, and heart medications. Grapefruit juice and other CYP inhibitors can also affect how tacrolimus is metabolized. Patients should inform their healthcare provider about all medications they are taking to avoid potential interactions.

Frequently Asked Questions

ENVARSUS PA 4 MG is used to prevent organ rejection in transplant patients by suppressing the immune system.

ENVARSUS PA 4 MG should be taken orally, usually once daily, and the extended-release tablet should not be crushed or chewed.

Common side effects may include headaches, tremors, and gastrointestinal issues. Patients should consult their healthcare provider if these effects persist or worsen.

ENVARSUS PA 4 MG may interact with various medications, so it's important to discuss all current medications with a healthcare provider.

If a dose is missed, it should be taken as soon as possible unless it is almost time for the next dose. Patients should not double the dose to catch up.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.